Versican 3'-untranslated region (3'UTR) promotes dermal wound repair and fibroblast migration by regulating miRNA activity

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 7, 2014, Pages 1373-1385

  Yang, Weining ^a,b   Yee, Albert J M ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

3'UTR; CeRNA; MicroRNA; Non coding RNA; Transgenic mouse

Indexed keywords

BETA CATENIN; MESSENGER RNA; MICRORNA; MICRORNA 185; MICRORNA 203; MICRORNA 434 3P; MICRORNA 680; MICRORNA 690; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VERSICAN; 3' UNTRANSLATED REGION; CTNNB1 PROTEIN, MOUSE; LUCIFERASE;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL ACTIVITY; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA VECTOR; SKIN BIOPSY; TRANSGENE; UPREGULATION; WESTERN BLOTTING; WILD TYPE; WOUND HEALING; 3T3 CELL LINE; ANIMAL; C57BL MOUSE; CBA MOUSE; CELL MOTION; DERMIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; BETA CATENIN; CELL MOVEMENT; DERMIS; GENE EXPRESSION REGULATION; GENES, REPORTER; LUCIFERASES; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MICRORNAS; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VERSICANS; WOUND HEALING;

EID: 84899132438     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.02.015     Document Type: Article

References (73)

1. Sen C.K., Roy S. Redox signals in wound healing. Biochim. Biophys. Acta 2008, 1780:1348-1361.
2. Shilo S., Roy S., Khanna S., Sen C.K. MicroRNA in cutaneous wound healing: a new paradigm. DNA Cell Biol. 2007, 26:227-237.
3. Greaves N.S., Ashcroft K.J., Baguneid M., Bayat A. Current understanding of molecular and cellular mechanisms in fibroplasia and angiogenesis during acute wound healing. J. Dermatol. Sci. 2013, 72:206-217.
4. Kanitakis J. Anatomy, histology and immunohistochemistry of normal human skin. Eur. J. Dermatol. 2002, 12:390-399. (quiz 400-391).
5. Wu Y.J., La Pierre D.P., Wu J., Yee A.J., Yang B.B. The interaction of versican with its binding partners. Cell Res. 2005, 15:483-494.
6. Wight T.N. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr. Opin. Cell Biol. 2002, 14:617-623.
7. Shinomura T., Nishida Y., Ito K., Kimata K. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J. Biol. Chem. 1993, 268:14461-14469.
8. Nadanaka S., Sato C., Kitajima K., Katagiri K., Irie S., Yamagata T. Occurrence of oligosialic acids on integrin alpha 5 subunit and their involvement in cell adhesion to fibronectin. J. Biol. Chem. 2001, 276:33657-33664.
9. Henderson D.J., Copp A.J. Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ. Res. 1998, 83:523-532.
10. LeBaron R.G., Zimmermann D.R., Ruoslahti E. Hyaluronate binding properties of versican. J. Biol. Chem. 1992, 267:10003-10010.
11. Yang B.L., Zhang Y., Cao L., Yang B.B. Cell adhesion and proliferation mediated through the G1 domain of versican. J. Cell. Biochem. 1999, 72:210-220.
12. Zheng P.S., Vais D., Lapierre D., Liang Y.Y., Lee V., Yang B.L., Yang B.B. PG-M/versican binds to P-selectin glycoprotein ligand-1 and mediates leukocyte aggregation. J. Cell Sci. 2004, 117:5887-5895.
13. Ang L.C., Zhang Y., Cao L., Yang B.L., Young B., Kiani C., Lee V., Allan K., Yang B.B. Versican enhances locomotion of astrocytoma cells and reduces cell adhesion through its G1 domain. J. Neuropathol. Exp. Neurol. 1999, 58:597-605.
14. Evanko S.P., Raines E.W., Ross R., Gold L.I., Wight T.N. Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor beta. Am. J. Pathol. 1998, 152:533-546.
15. Zhang Y., Wu Y., Cao L., Lee V., Chen L., Lin Z., Kiani C., Adams M.E., Yang B.B. Versican modulates embryonic chondrocyte morphology via the epidermal growth factor-like motifs in G3. Exp. Cell Res. 2001, 263:33-42.
16. Sheng W., Wang G., La Pierre D.P., Wen J., Deng Z., Wong C.K., Lee D.Y., Yang B.B. Versican mediates mesenchymal-epithelial transition. Mol. Biol. Cell 2006, 17:2009-2020.
17. Zheng P.S., Wen J., Ang L.C., Sheng W., Viloria-Petit A., Wang Y., Wu Y., Kerbel R.S., Yang B.B. Versican/PG-MG3 domain promotes tumor growth and angiogenesis. FASEB J. 2004, 18:754-756.
18. Shatseva T., Lee D.Y., Deng Z., Yang B.B. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J. Cell Sci. 2011, 124:2826-2836.
19. Rutnam Z.J., Yang B.B. The non-coding 3' UTR of CD44 induces metastasis by regulating extracellular matrix functions. J. Cell Sci. 2012, 125:2075-2085.
20. Tian Y., Luo A., Cai Y., Su Q., Ding F., Chen H., Liu Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 2010, 285:7986-7994.
21. Wu Q.P., Xie Y.Z., Deng Z., Li X.M., Yang W., Jiao C.W., Fang L., Li S.Z., Pan H.H., Yee A.J., Lee D.Y., Li C., Zhang Z., Guo J., Yang B.B. Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistance. PLoS One 2012, 7:e44579.
22. Siragam V., Rutnam Z.J., Yang W., Fang L., Luo L., Yang X., Li M., Deng Z., Qian J., Peng C., Yang B.B. MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11. Oncotarget 2012, 1370-1385.
23. Wang C.H., Lee D.Y., Deng Z., Jeyapalan Z., Lee S.C., Kahai S., Lu W.Y., Zhang Y., Yang B.B. MicroRNA miR-328 regulates zonation morphogenesis by targeting CD44 expression. PLoS One 2008, 3:e2420.
24. Shan S.W., Lee D.Y., Deng Z., Shatseva T., Jeyapalan Z., Du W.W., Zhang Y., Xuan J.W., Yee S.P., Siragam V., Yang B.B. MicroRNA MiR-17 retards tissue growth and represses fibronectin expression. Nat. Cell Biol. 2009, 11:1031-1038.
25. Lee D.Y., Deng Z., Wang C.H., Yang B.B. MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:20350-20355.
26. Nohata N., Hanazawa T., Enokida H., Seki N. MicroRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers. Oncotarget 2012, 3:9-21.
27. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., Nair S., Egan D.A., Li A., Huang G., Klein-Szanto A.J., Gimotty P.A., Katsaros D., Coukos G., Zhang L., Pure E., Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat. Cell Biol. 2008, 10:202-210.
28. Jeyapalan Z., Deng Z., Shatseva T., Fang L., He C., Yang B.B. Expression of CD44 3'-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 2011, 39:3026-3041.
29. Lee D.Y., Shatseva T., Jeyapalan Z., Du W.W., Deng Z., Yang B.B. A 3'-untranslated region (3'UTR) induces organ adhesion by regulating miR-199a* functions. PLoS One 2009, 4:e4527.
30. Fang L., Du W.W., Yang X., Chen K., Ghanekar A., Levy G., Yang W., Yee A.J., Lu W.Y., Xuan J.W., Gao Z., Xie F., He C., Deng Z., Yang B.B. Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 2013, 27:907-919.
31. Swami M. Small RNAs: Pseudogenes act as microRNA decoys. Nat. Rev. Cancer 2010, 10:535.
32. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W.J., Pandolfi P.P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
33. Cesana M., Cacchiarelli D., Legnini I., Santini T., Sthandier O., Chinappi M., Tramontano A., Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011, 147:358-369.
34. Lee D.Y., Jeyapalan Z., Fang L., Yang J., Zhang Y., Yee A.Y., Li M., Du W.W., Shatseva T., Yang B.B. Expression of versican 3'-untranslated region modulates endogenous microRNA functions. PLoS One 2010, 5:e13599.
35. LaPierre D.P., Lee D.Y., Li S.Z., Xie Y.Z., Zhong L., Sheng W., Deng Z., Yang B.B. The ability of versican to simultaneously cause apoptotic resistance and sensitivity. Cancer Res. 2007, 67:4742-4750.
36. He J., Wu J., Xu N., Xie W., Li M., Li J., Jiang Y., Yang B.B., Zhang Y. MiR-210 disturbs mitotic progression through regulating a group of mitosis-related genes. Nucleic Acids Res. 2013, 41:498-508.
37. Rahmani M., Carthy J.M., McManus B.M. Mapping of the Wnt/beta-catenin/TCF response elements in the human versican promoter. Methods Mol. Biol. 2012, 836:35-52.
38. Zimmermann D.R., Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J. 1989, 8:2975-2981.
39. Yamagata M., Shinomura T., Kimata K. Tissue variation of two large chondroitin sulfate proteoglycans (PG-M/versican and PG-H/aggrecan) in chick embryos. Anat. Embryol. (Berl.) 1993, 187:433-444.
40. Yao L.Y., Moody C., Schonherr E., Wight T.N., Sandell L.J. Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol. 1994, 14:213-225.
41. Zimmermann D.R., Dours-Zimmermann M.T., Schubert M., Bruckner-Tuderman L. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J. Cell Biol. 1994, 124:817-825.
42. Zako M., Shinomura T., Miyaishi O., Iwaki M., Kimata K. Transient expression of PG-M/versican, a large chondroitin sulfate proteoglycan in developing chicken retina. J. Neurochem. 1997, 69:2155-2161.
43. Aspberg A., Binkert C., Ruoslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:10590-10594.
44. Yamagata M., Yamada K.M., Yoneda M., Suzuki S., Kimata K. Chondroitin sulfate proteoglycan (PG-M-like proteoglycan) is involved in the binding of hyaluronic acid to cellular fibronectin. J. Biol. Chem. 1986, 261:13526-13535.
45. Aspberg A., Miura R., Bourdoulous S., Shimonaka M., Heinegard D., Schachner M., Ruoslahti E., Yamaguchi Y. The C-type lectin domains of lecticans, a family of aggregating chondroitin sulfate proteoglycans, bind tenascin-R by protein-protein interactions independent of carbohydrate moiety. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10116-10121.
46. Aspberg A., Adam S., Kostka G., Timpl R., Heinegard D. Fibulin-1 is a ligand for the C-type lectin domains of aggrecan and versican. J. Biol. Chem. 1999, 274:20444-20449.
47. Kawashima H., Hirose M., Hirose J., Nagakubo D., Plaas A.H., Miyasaka M. Binding of a large chondroitin sulfate/dermatan sulfate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J. Biol. Chem. 2000, 275:35448-35456.
48. Isogai Z., Aspberg A., Keene D.R., Ono R.N., Reinhardt D.P., Sakai L.Y. Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J. Biol. Chem. 2002, 277:4565-4572.
49. Wu Y., Chen L., Zheng P.S., Yang B.B. Beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J. Biol. Chem. 2002, 277:12294-12301.
50. Evanko S.P., Angello J.C., Wight T.N. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 1999, 19:1004-1013.
51. Ricciardelli C., Russell D.L., Ween M.P., Mayne K., Suwiwat S., Byers S., Marshall V.R., Tilley W.D., Horsfall D.J. Formation of hyaluronan- and versican-rich pericellular matrix by prostate cancer cells promotes cell motility. J. Biol. Chem. 2007, 282:10814-10825.
52. Wight T.N., Merrilees M.J. Proteoglycans in atherosclerosis and restenosis: key roles for versican. Circ. Res. 2004, 94:1158-1167.
53. Zhang Y., Cao L., Yang B.L., Yang B.B. The G3 domain of versican enhances cell proliferation via epidermial growth factor-like motifs. J. Biol. Chem. 1998, 273:21342-21351.
54. Sheng W., Wang G., Wang Y., Liang J., Wen J., Zheng P.S., Wu Y., Lee V., Slingerland J., Dumont D., Yang B.B. The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol. Biol. Cell 2005, 16:1330-1340.
55. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127:469-480.
56. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
57. Maretzky T., Reiss K., Ludwig A., Buchholz J., Scholz F., Proksch E., de Strooper B., Hartmann D., Saftig P. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9182-9187.
58. Shao M.Y., Cheng R., Wang F.M., Yang H., Cheng L., Hu T. Beta-catenin and Rho GTPases as downstream targets of TGF-beta1 during pulp repair. Cell Biol. Int. 2011, 35:105-109.
59. Cheon S.S., Nadesan P., Poon R., Alman B.A. Growth factors regulate beta-catenin-mediated TCF-dependent transcriptional activation in fibroblasts during the proliferative phase of wound healing. Exp. Cell Res. 2004, 293:267-274.
60. Cheon S.S., Cheah A.Y., Turley S., Nadesan P., Poon R., Clevers H., Alman B.A. Beta-catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6973-6978.
61. Merrilees M., Beaumont B., Scott L., Hermanutz V., Fennessy P. Effect of TGF-beta(1) antisense S-oligonucleotide on synthesis and accumulation of matrix proteoglycans in balloon catheter-injured neointima of rabbit carotid arteries. J. Vasc. Res. 2000, 37:50-60.
62. Jian H., Shen X., Liu I., Semenov M., He X., Wang X.F. Smad3-dependent nuclear translocation of beta-catenin is required for TGF-beta1-induced proliferation of bone marrow-derived adult human mesenchymal stem cells. Genes Dev. 2006, 20:666-674.
63. Chen Y., Whetstone H.C., Lin A.C., Nadesan P., Wei Q., Poon R., Alman B.A. Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing. PLoS Med. 2007, 4:e249.
64. Glass D.A., Bialek P., Ahn J.D., Starbuck M., Patel M.S., Clevers H., Taketo M.M., Long F., McMahon A.P., Lang R.A., Karsenty G. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 2005, 8:751-764.
65. Kneidinger N., Yildirim A.O., Callegari J., Takenaka S., Stein M.M., Dumitrascu R., Bohla A., Bracke K.R., Morty R.E., Brusselle G.G., Schermuly R.T., Eickelberg O., Konigshoff M. Activation of the WNT/beta-catenin pathway attenuates experimental emphysema. Am. J. Respir. Crit. Care Med. 2011, 183:723-733.
66. Flozak A.S., Lam A.P., Russell S., Jain M., Peled O.N., Sheppard K.A., Beri R., Mutlu G.M., Budinger G.R., Gottardi C.J. Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells. J. Biol. Chem. 2010, 285:3157-3167.
67. Adamson A., Perkins S., Brambilla E., Tripp S., Holden J., Travis W., Guinee D. Proliferation, C-myc, and cyclin D1 expression in diffuse alveolar damage: potential roles in pathogenesis and implications for prognosis. Hum. Pathol. 1999, 30:1050-1057.
68. Liu W., Dong X., Mai M., Seelan R.S., Taniguchi K., Krishnadath K.K., Halling K.C., Cunningham J.M., Boardman L.A., Qian C., Christensen E., Schmidt S.S., Roche P.C., Smith D.I., Thibodeau S.N. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 2000, 26:146-147.
69. Yi R., Poy M.N., Stoffel M., Fuchs E. A skin microRNA promotes differentiation by repressing 'stemness'. Nature 2008, 452:225-229.
70. Takahashi Y., Forrest A.R., Maeno E., Hashimoto T., Daub C.O., Yasuda J. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS One 2009, 4:e6677.
71. Liu M., Lang N., Chen X., Tang Q., Liu S., Huang J., Zheng Y., Bi F. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells. Cancer Lett. 2011, 301:151-160.
72. Liao J.M., Lu H. Autoregulatory suppression of c-Myc by miR-185-3p. J. Biol. Chem. 2011, 286:33901-33909.
73. Yang Y., Li Y., Wang Y., Wu J., Yang G., Yang T., Gao Y., Lu Y. Versican gene: regulation by the beta-catenin signaling pathway plays a significant role in dermal papilla cell aggregative growth. J. Dermatol. Sci. 2012, 68:157-163.